Kuwait Heart Foundation Registry of Acute Coronary Events
KHF RACE
1 other identifier
observational
10,812
1 country
1
Brief Summary
Acute coronary syndrome (ACS) is the most common presentation of Coronary Artery Disease (CAD). It causes significant morbidity and mortality. The Gulf Registry of Acute Coronary Events (Gulf RACE) was conducted in 2007 and filled a wide gap in our understanding of ACS and its management in Kuwait and the Arabian Gulf region. However, the management of ACS has undergone tremendous advances over the last two decades involving pharmacotherapy and device therapy. Practice guidelines have also changed over the last decade. For example, in 2007, there was no catheterization laboratory in any of the general hospitals in Kuwait, primary percutaneous coronary intervention (PCI) was not being practiced, and the rate of in-hospital cardiac catheterization for all ACS patients was very low at around 10%. Currently, of the eight general hospitals in Kuwait, six have catheterization laboratories and five of the six serve as primary PCI centers. There is no contemporary ACS registry in Kuwait, studying its incidence, management, and influence of current changes in clinical practice on patients' outcomes. This multicentre disease-based, country-wide registry is guided by the American Heart Association policy statement for expanding the applications of existing and future clinical registries and the User's Guide published by the Agency for Health care Research and Quality guidance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2023
CompletedFirst Posted
Study publicly available on registry
May 15, 2023
CompletedStudy Start
First participant enrolled
May 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedAugust 20, 2025
March 1, 2025
1.5 years
May 2, 2023
August 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Mortality
To measure the adverse outcome of in-hospital mortality in ACS patients in Kuwait.
through study completion, an average of 6 months
Major Adverse Cardiac Events (MACE)
To measure the in-hospital adverse outcomes like myocardial infarction (MI), cerebrovascular accident (CVA), bleeding, cardiogenic shock, heart failure and others in ACS patients in Kuwait.
through study completion, an average of 6 months
Secondary Outcomes (6)
Mortality
30 days from discharge
Major Adverse Cardiac Events (MACE)
30 days from discharge
Rehospitalization
within 30 days from discharge
Revascularization
within 30 days from discharge
Lipid level control
At 6 months from ACS event
- +1 more secondary outcomes
Study Arms (1)
ACS patients
Patients admitted to hospital with diagnosis of ACS.
Interventions
Eligibility Criteria
Patients who are admitted to any of the eight general hospitals in Kuwait with a diagnosis of ACS. The sample size will be 10,000 patients. ACS diagnosis includes ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI) and unstable angina.
You may qualify if:
- Patient is admitted to hospital with admission diagnosis of ACS.
- Patient or a relative consent to enrolment in the registry.
You may not qualify if:
- Refusal or inability to consent for enrolment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gulf Heart Associationlead
- Serviercollaborator
- Sanoficollaborator
- Beshara companycollaborator
- Kuwait Heart Foundationcollaborator
Study Sites (1)
Mubarak Al Kabeer hospital
Kuwait City, Kuwait, 13110, Kuwait
Study Officials
- PRINCIPAL INVESTIGATOR
Mohammad Zubaid, Professor
Kuwait University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 2, 2023
First Posted
May 15, 2023
Study Start
May 15, 2023
Primary Completion
November 25, 2024
Study Completion
June 30, 2025
Last Updated
August 20, 2025
Record last verified: 2025-03